Sexual Activity, Function and Dysfunction After a Diagnosis of Bladder Cancer. Issue 9 (21st July 2022)

• Record Type: Journal Article
• Authors: Jubber, Ibrahim; Rogers, Zoe; Catto, James WF; Bottomley, Sarah; Glaser, Adam; Downing, Amy; Absolom, Kate
• Is Part Of: Journal of sexual medicine. Volume 19:Issue 9(2022)
• Page Start: 1431
• Page End: 1441
• Publication Date: 2022-07-21
• Subjects: Bladder Cancer -- Quality of Life -- HRQOL -- Patient Reported Outcomes -- EQ5D, Sexual Function -- Erectile Dysfunction; Sexual disorders -- Periodicals; Sex -- Periodicals; Sexual health -- Periodicals; 616.69005
• DOI: 10.1016/j.jsxm.2022.06.016
• Languages: English
• ISSNs: 1743-6095

Abstract

ABSTRACT: Background: Sexual dysfunction is common in those affected by cancer and local and radical treatments for Bladder Cancer (BC) can affect sexual function directly. Aim: To evaluate sexual function following a bladder cancer (BC) diagnosis. Methods: Self-reported sexual function was collected 10 years after a diagnosis of BC as part of a cross-sectional patient reported outcome measure (PROM) survey exploring life after BC diagnosis and treatment. Outcomes: Participants completed a combined EORTC QLQ-BLM30 and QLQ-NMIBC24 questionnaire, including questions on sexual activity, intimacy, erectile/ejaculatory function and vaginal dryness. Results: A total of 1796 participants returned a completed survey out of 3279 eligible participants (55%). Of the participants who returned a completed survey, a total of 1530 (85%) participants answered sexual function questions. The median (IQR) age was 75 (70–81). Participants were predominantly men (78%) and married/in civil partnerships (66%). In total, 31% were sexually active. Vaginal dryness was common (66%) in women. Erectile and ejaculatory dysfunction (80% and 58% respectively) were common in men. Compared to TURBT +/- intravesical treatments, those who had radical treatment were less likely to be sexually active (adjusted OR 0.56, 95% CI: 0.44–0.72, P <0.001) and had worse mean scores for intimacy problems (29.1 [radical treatment] vs 12.1, P <0.001), male sexual problems (72.2 [radical treatment] vs 45.7, P <0.001) and overall sexual function (17.1 [radical treatment] vs 20.3, P =0.01). Clinical Implications: These findings highlight the magnitude of sexual dysfunction in the BC patient cohort and can help inform patients during the pre-op counselling process and shared decision making prior to BC treatments. Strengths and Limitations: This study provides the largest in-depth analysis of sexual activity and function after BC diagnosis and treatment, to date. Limitations include the lack of data on participants' sexual function prior to BC treatment and the heterogeneity with respect to time passed since last BC treatment. Conclusion: Sexual dysfunction in BC patients is common and rates appear higher following radical treatments compared to endoscopic. It is important to elicit these problems in clinics to enable counselling and treatment.